Hap Trading, LLC Invitae Corp Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $102,723 - $200,345	-6,988 Reduced 16.23%	36,058 $551,000
Q3 2021 Nov 10, 2021	BUY	$24.31 - $33.6 $354,974 - $490,627	14,602 Added 51.34%	43,046 $1.22 Million
Q2 2021 Aug 11, 2021	BUY	$26.09 - $40.4 $281,615 - $436,077	10,794 Added 61.16%	28,444 $959,000
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $38,614 - $66,494	1,168 Added 7.09%	17,650 $674,000
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $34,670 - $52,434	-1,996 Reduced 10.8%	16,482 $387,000
Q1 2019 May 10, 2019	BUY	$10.65 - $25.75 $196,790 - $475,808	18,478 New	18,478 $433,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.